BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4562170)

  • 1. Recent progress in the formulation of vehicles for topical applications.
    Hadgraft JW
    Br J Dermatol; 1972 Oct; 87(4):386-9. PubMed ID: 4562170
    [No Abstract]   [Full Text] [Related]  

  • 2. Extemporaneous formulation of corticosteroids for topical usage.
    Burdick KH; Poulsen B; Place VA
    JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
    [No Abstract]   [Full Text] [Related]  

  • 3. Ability of certain additives to influence the absorption of salicylic acid from solutions in an in vivo study: preliminary report.
    Whitworth CW; Yantis LD
    J Pharm Sci; 1967 Dec; 56(12):1661-3. PubMed ID: 5588724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of vehicle composition on the liberation and percutaneous penetration of corticosteroids].
    Moës-Henschel V; Jaminet F
    J Pharm Belg; 1975; 30(4):390-404. PubMed ID: 1206464
    [No Abstract]   [Full Text] [Related]  

  • 5. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamic observation of topical penetration of substances through the skin barrier].
    Salanský I; Valosek P; Dostál M
    Cesk Dermatol; 1970 Jan; 45(1):36-41. PubMed ID: 5523624
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy.
    Maibach HI
    Dermatologica; 1976; 152 Suppl 1():11-25. PubMed ID: 955232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new type of topical corticoid. Principle and experimental activity control].
    Escande JP
    Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption of drugs from the skeletal muscle of the rats. 3. Effect of water-soluble adjuvants and vehicles on the intramuscular absorption.
    Kakemi K; Sezaki H; Okumura K; Kobayashi H; Furusawa S
    Chem Pharm Bull (Tokyo); 1972 Mar; 20(3):443-51. PubMed ID: 5034718
    [No Abstract]   [Full Text] [Related]  

  • 10. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous absorption.
    Brisson P
    Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous absorption.
    Idson B
    J Pharm Sci; 1975 Jun; 64(6):901-24. PubMed ID: 1094104
    [No Abstract]   [Full Text] [Related]  

  • 15. Vehicle effects on in vitro percutaneous absorption through rat and human skin.
    Hilton J; Woollen BH; Scott RC; Auton TR; Trebilcock KL; Wilks MF
    Pharm Res; 1994 Oct; 11(10):1396-400. PubMed ID: 7855041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disintegration of tablets.
    Lowenthal W
    J Pharm Sci; 1972 Nov; 61(11):1695-711. PubMed ID: 4569113
    [No Abstract]   [Full Text] [Related]  

  • 17. The percutaneous absorption of phenolic compounds: the effect of vehicles on the penetration of phenol.
    Roberts MS; Anderson RA
    J Pharm Pharmacol; 1975 Aug; 27(8):599-605. PubMed ID: 239176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorption of drug substances into the blood].
    Prishchep TP
    Farmatsiia; 1980; 29(2):68-71. PubMed ID: 6991294
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 20. Dependence of corticosteroid penetration on the vehicle.
    Polano MK; Ponec M
    Arch Dermatol; 1976 May; 112(5):675-80. PubMed ID: 1275523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.